Detalles de la búsqueda
1.
Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial.
Am Heart J
; 176: 28-35, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27264217
2.
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
Lancet
; 383(9915): 413-23, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24183564
3.
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years.
JACC Cardiovasc Interv
; 13(9): 1100-1109, 2020 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32381186
4.
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.
JACC Cardiovasc Interv
; 11(5): 462-469, 2018 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29519378
5.
Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial.
Clin Res Cardiol
; 105(3): 206-15, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26329584
Resultados
1 -
5
de 5
1
Próxima >
>>